Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis

Gut

Volumn 58, Issue 6, 2009, Pages 799-804

  Festen, E A M ^a   Goyette, P ^b   Scott, R ^c   Annese, V ^d   Zhernakova, A ^e   Lian, J ^b   Lefebvre C ^b   Brant, S R ^f   Cho, J H ^g   Silverberg, M S ^h   Taylor, K D ⁱ   De Jong, D J ^j   Stokkers, P C ^k   Mcgovern, D ^k   Palmieri, O ^d   Achkar, J P ^l   Xavier, R J ^m   Daly, M J ^m   Duerr, R H ^c   Wijmenga, C ^b   Weersma, R K ^a   Rioux, J D ^b   more..

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b MONTREAL HEART INSTITUTE   (Canada)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g YALE UNIVERSITY   (United States)

^h UNIVERSITY OF TORONTO   (Canada)

ⁱ CEDARS SINAI MEDICAL CENTER   (United States)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^k ACADEMIC MEDICAL CENTER   (Netherlands)

^l LERNER RESEARCH INSTITUTE   (United States)

^m MASSACHUSETTS GENERAL HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 2; INTERLEUKIN 21;

ALLELE; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

EID: 64549104048     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gut.2008.166918     Document Type: Article

References (32)

1. Baumgart DC, Carding SR. Inflammatory bowel disease: cause and immunobiology. Lancet 2007;369:1627-1640 (Pubitemid 46722636)
2. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 2007;369:1641-1657 (Pubitemid 46722637)
3. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet 2008;40:955-962
4. Franke A, Balschun T, Karlsen TH, et al. Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility. Nat Genet 2008;40:1319-1323
5. Silverberg MS, Cho JH, Rioux JD, et al. Ulcerative colitis-linked loci on chromosome 1p36 and 12q15 found by genome-wide association study. Nat Genet 2009;41:216-220
6. van Heel DA, Franke L, Hunt KA, et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet 2007;39:827-829 (Pubitemid 47014494)
7. Todd JA, Walker NM, Cooper JD, et al. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nat Genet 2007;39:857-864 (Pubitemid 47018195)
8. Zhernakova A, Alizadeh BZ, Bevova M, et al. Novel association in chromosome 4q27 region with rheumatoid arthritis and confirmation of type 1 diabetes point to a general risk locus for autoimmune diseases. Am J Hum Genet 2007;81:1284-1288 (Pubitemid 350211457)
9. Sawalha AH, Kaufman KM, Kelly JA, et al. Genetic association of interleukin-21 polymorphisms with systemic lupus erythematosus. Ann Rheum Dis 2008;67:458-461
10. Liu Y, Helms C, Liao W, et al. A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008;4(3):e1000041.
11. Smyth DJ, Plagnol V, Walker NM, et al. Shared and distinct genetic variants in type 1 diabetes and celiac disease. N Engl J Med 2008;359:2767-2777
12. Sanchez E, Morales S, Paco L, et al. Interleukin 12 (IL12B), interleukin 12 receptor (IL12RB1) and interleukin 23 (IL23A) gene polymorphism in systemic lupus erythematosus. Rheumatology (Oxford) 2005;44:1136-1139 (Pubitemid 41236020)
13. Randolph AG, Lange C, Silverman EK, et al. The IL12B gene is associated with asthma. Am J Hum Genet 2004;75:709-715 (Pubitemid 39244786)
14. Fisher SA, Tremelling M, Anderson CA, et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease. Nat Genet 2008;40:710-712
15. Hunt KA, Zhernakova A, Turner G, et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat Genet 2008;40:395-402.
16. Zhernakova A, Festen EM, Franke L, et al. Genetic analysis of innate immunity in Crohn's disease and ulcerative colitis identifies two susceptibility loci harboring CARD9 and IL18RAP. Am J Hum Genet 2008;82:1202-1210
17. Monteleone G, Monteleone I, Fina D, et al. Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease. Gastroenterology 2005;128:687-694 (Pubitemid 40585371)
18. Sadlack B, Merz H, Schorle H, et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 1993;75:253-261 (Pubitemid 23320289)
19. Weersma RK, Stokkers PC, van Bodegraven AA, et al. Molecular prediction of disease risk and severity in a large Dutch Crohn's disease cohort. Gut 2009;58:388-395
20. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006;314:1461-1463 (Pubitemid 44871953)
21. Rioux JD, Xavier RJ, Taylor KD, et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 2007;39:596-604. (Pubitemid 46676115)
22. Tello-Ruiz MK, Curley C, DelMonte T, et al. Haplotype-based association analysis of 56 functional candidate genes in the IBD6 locus on chromosome 19. Eur J Hum Genet 2006;14:780-790 (Pubitemid 43797277)
23. De Jager PL, Franchimont D, Waliszewska A, et al. The role of the Toll receptor pathway in susceptibility to inflammatory bowel diseases. Genes Immun 2007;8:387-397 (Pubitemid 47163102)
24. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics 2003;19:149-150
25. Dixon AL, Liang L, Moffatt MF, et al. A genome-wide association study of global gene expression. Nat Genet 2007;39:1202-1207 (Pubitemid 47482680)
26. Thornton AM, Donovan EE, Piccirillo CA, et al. Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function. J Immunol 2004;172:6519-6523 (Pubitemid 38669083)
27. Leonard WJ, Spolski R. Interleukin-21: a modulator of lymphoid proliferation, apoptosis and differentiation. Nat Rev Immunol 2005;5:688-698 (Pubitemid 43086171)
28. Lichtiger S, Present DH, Kornbluth A, et al. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-1845 (Pubitemid 24188135)
29. Van Assche G, Dalle I, Noman M, et al. A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis. Am J Gastroenterol 2003;98:369-376 (Pubitemid 36232388)
30. Wapenaar MC, Monsuur AJ, van Bodegraven AA, et al. Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitis. Gut 2008;57:463-467
31. Monsuur AJ, de Bakker PI, Alizadeh BZ, et al. Myosin IXB variant increases the risk of celiac disease and points toward a primary intestinal barrier defect. Nat Genet 2005;37:1341-1344 (Pubitemid 41722189)
32. van Bodegraven AA, Curley CR, Hunt KA, et al. Genetic variation in myosin IXB is associated with ulcerative colitis. Gastroenterology 2006;131:1768-1774 (Pubitemid 44958512)